Cambridge Healthcare Research, a life sciences and healthcare consultancy, has named Chris Stevenson as its new director, it was reported yesterday.
The new director was a former Johnson and Johnson, Cello Health and Thompson Reuters president. He is now working at global strategic marketing consultancy, Osprey Health Consulting, and has more than 30 years' experience in the pharmaceutical and professional services industry.
Stevenson's appointment is part of Cambridge's effort to scale, and increase the value of its offerings to present and new clients in product strategy, commercialisation and in competitor analysis.
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar